<DOC>
	<DOCNO>NCT00525057</DOCNO>
	<brief_summary>The primary endpoint study would determine safety dalteparin prophylaxis deep venous thrombosis ( DVT ) orthopaedic oncology patient . Specifically , goal study determine whether significantly increase bleeding complication surgical site major oncologic operation low extremity . The study would help establish specific parameter use dalteparin complex orthopaedic oncology patient . Not patient would appropriate medication , particularly massive hemorrhage surgery underlie coagulopathies . It likely patient require limited tumor excision , particularly metastatic carcinoma , would ideal candidate dalteparin therapy . Patients require radical resection tumor may need strict guideline safe use medication , since potential post-operative bleeding may great .</brief_summary>
	<brief_title>DVT Prophylaxis Orthopaedic Oncology Patients - A Safety Study</brief_title>
	<detailed_description>Dalteparin FDA-approved blood thinner ( prevents clot thin blood ) . Before start treatment study , call `` screening test . '' These test help doctor decide eligible take part study . You complete medical history , physical exam Doppler ultrasound leg . The Doppler ultrasound test use sound wave check vein legs presence pre-existing deep venous thrombosis ( blood clot ) . You also blood drawn routine blood test ( 2 tablespoon ) . Women able child must negative blood urine pregnancy test take part study . You proceed schedule surgery regardless whether take part study . During surgery , TED hose mechanical compression stock put leg surgery . TED stand thromboembolic disease , mean `` blood clot '' . TED hose special stocking wear legs prevent blood clotting . Mechanical compression stocking air fill stocking inflate deflate intermittently . You TED hose mechanical compression stocking apply leg surgery recovery room . You monitor daily physical exam sign deep venous thrombosis ( DVT - blood clot ) DVT vein leg . Within 12-24 hour follow surgery remove bone tumor , begin treatment dalteparin . You receive injection dalteparin every day injection give deep skin . The injection site vary day give daily discharge hospital ( 7-10 day ) . You also blood drawn routine blood test follow surgery ( 2 tablespoon ) . A follow-up Doppler ultrasound study leg surgery do discharge hospital . Participants experience complication follow surgery , include DVT , immediately treat standard care procedure . Your participation study time discharge hospital . This investigational study . Dalteparin FDA-approved blood thinner . Its use together TED hose mechanical compression stocking study experimental . The TED hose mechanical compression stocking use study consider standard care . Up 70 patient take part study . All enrol M. D. Anderson .</detailed_description>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Osteosarcoma</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<criteria>1 . Group A : Metastatic disease , myeloma , lymphoma ; 2 . Group A : Pathologic fracture impend pathologic fracture femur ; 3 . Group A : Intramedullary rod , plating , cementation , hip arthroplasty , knee arthroplasty . 4 . Group B : Primary sarcoma bone soft tissue low extremity . 5 . Group B : T2 tu ; mor ( &gt; 5 cm buty &lt; 20 cm ) ; 6 . Group B : Radical resection tumor , may necessitate major bone soft tissue reconstruction . 1 . Presence DVT preoperative screening ultrasound study 2 . Massive tumor ( &gt; 20 cm great dimension ) 3 . Amputation affect leg treatment tumor 4 . Estimated blood loss &gt; 2 liter surgery 5 . Surgical drain output &gt; 500 cc bloody fluid first 8 hour 6 . I.N.R . &gt; 1.3 preoperatively &gt; 1.5 postoperatively 7 . Platelet count &lt; 100,000 either preoperatively postoperatively 8 . Indwelling postoperative epidural catheter pain control 9 . Age &lt; 30 year 10 . History underlie bleed disorder , hemophilia 11 . History adverse reaction heparin heparininduced thrombocytopenia 12 . Severe liver renal insufficiency 13 . History hypertensive diabetic retinopathy 14 . History gastrointestinal bleeding within 12 month 15 . Treatment warfarin , clopidogrel , aspirin , NSAIDs , LMWH anticoagulants condition 16 . History stroke 17 . Women child bear potential positive urine serum pregnancy test ( hCG ) time preoperative evaluation ( within 7 day surgery ) 18 . Women breastfeed 19 . Hemoglobin &lt; 8.0 g/dL 20 . Platelet count &lt; 100,000 /L 21 . Alanine aminotransferase &gt; 100 IU/L 22 . Aspartate aminotransferase &gt; 100 IU/L 23 . Direct bilirubin &gt; 0.5mg/dL 24 . Serum creatinine &gt; 2.0 mg/dL 25 . Patients take COX2 inhibitor 26 . Patients fragment mechanical heart valve</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Bone Cancer</keyword>
	<keyword>Orthopaedic Oncology</keyword>
	<keyword>Orthopaedics</keyword>
	<keyword>Myeloma</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Deep Venous Thrombosis</keyword>
	<keyword>DVT Prophylaxis</keyword>
	<keyword>Thromboembolic disease</keyword>
	<keyword>Blood clot</keyword>
	<keyword>Dalteparin</keyword>
	<keyword>Fragmin</keyword>
	<keyword>Surgery</keyword>
	<keyword>Bone Tumor</keyword>
	<keyword>Tumor soft tissue</keyword>
	<keyword>Lower extremity</keyword>
	<keyword>Leg</keyword>
	<keyword>TED hose</keyword>
	<keyword>Mechanical compression stock</keyword>
</DOC>